1. Home
  2. BANL vs TVGN Comparison

BANL vs TVGN Comparison

Compare BANL & TVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BANL

CBL International Limited

HOLD

Current Price

$6.30

Market Cap

19.0M

Sector

Energy

ML Signal

HOLD

Logo Tevogen Bio Holdings Inc.

TVGN

Tevogen Bio Holdings Inc.

N/A

Current Price

$7.36

Market Cap

21.3M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
BANL
TVGN
Founded
2015
2020
Country
Malaysia
United States
Employees
N/A
N/A
Industry
Oil Refining/Marketing
Blank Checks
Sector
Energy
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
19.0M
21.3M
IPO Year
2022
2021

Fundamental Metrics

Financial Performance
Metric
BANL
TVGN
Price
$6.30
$7.36
Analyst Decision
Hold
Analyst Count
0
1
Target Price
N/A
N/A
AVG Volume (30 Days)
221.3K
4.0K
Earning Date
04-17-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.27
$0.14
52 Week High
$16.40
$12.03

Technical Indicators

Market Signals
Indicator
BANL
TVGN
Relative Strength Index (RSI) 38.26 59.86
Support Level $0.36 $6.41
Resistance Level $16.40 $7.42
Average True Range (ATR) 1.94 0.32
MACD -1.32 0.04
Stochastic Oscillator 4.72 91.93

Price Performance

Historical Comparison
BANL
TVGN

About BANL CBL International Limited

CBL International Ltd is a marine fuel logistics company that provides a one-stop solution for vessel refueling. In the bunkering industry, it is referred to as a bunkering facilitator. It facilitates vessel refueling between ship operators and local physical distributors/traders by purchasing marine fuel, including fossil fuel and alternative fuel, from its suppliers and arranging for the suppliers to deliver the fuel to the customers. The company's customer base comprises container liners, bulk carriers, and tankers. Geographically, the company generates a majority of its revenue from China, followed by Hong Kong, Malaysia, Singapore, South Korea, and other regions.

About TVGN Tevogen Bio Holdings Inc.

Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs or CTLs), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders. The first clinical product of ExacTcell, TVGN 489, is initially being developed to fill a critical gap in COVID-19 therapeutics for the immunocompromised and the high-risk elderly, with potential applications in both treatment and prevention of chronic, lingering symptoms of the disease (Long COVID). Viruses, including COVID-19, hijack cellular machinery to transform infected cells into virus production plants.

Share on Social Networks: